Zobrazeno 1 - 10
of 13
pro vyhledávání: '"V S, Vakin"'
Autor:
V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, L. V. Lyalina, V. A. Marchenko, I. Yu. Nikonorov, M. P. Grudinin
Publikováno v:
Инфекция и иммунитет, Vol 12, Iss 1, Pp 158-164 (2021)
Currently, the assessment of the immunogenic properties of influenza viruses as a part of influenza vaccines is carried out by using seroprotection, seroconversion as well as the rate of increases in post-vaccination antibodies. At the same time, sig
Externí odkaz:
https://doaj.org/article/64822ca4a26f4346a87f70b3074e911b
Autor:
V. S. Vakin, O. S. Konshina, E. M. Wojciechowska, E. V. Kuznetsova, V. G. Mayorova, A. A. Vasilyeva, I. Yu. Nikonorov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 5, Pp 28-32 (2017)
Antiepidemic measures were limited effectiveness for several years Objectives of this research were formulated as an assessment of the immunogenicity activity of the influenza virus A(H1N1)pdm09 in the composition of modern trivaccines Immunogenicity
Externí odkaz:
https://doaj.org/article/21916a26ea2f423c980ddc8b484c2699
Autor:
A. A. Vasileva, V. Z. Krivitskaya, E. M. Vojcekhovskaya, V. S. Vakin, E. V. Kuznecova, E. R. Petrova, A. A. Go, N. I. Lvov, A. A. Sominina
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 15, Iss 2, Pp 77-84 (2016)
An isotypic structure of system antibody response to influenza A(H1N1)pdm09 was analyzed in adult volunteers vaccinated with two inactivated monovalent subunit vaccines against pandemic influenza. The comparison group consisted of patients infected w
Externí odkaz:
https://doaj.org/article/36ad4840b6bc4d4bb6412cf85929dae3
Autor:
V. S. Vakin, I. V. Amosova, E. M. Vojcekhovskaya, T. A. Timoshicheva, A. A. Vasileva, M. G. Pozdnyakova, L. V. Lyalina, V. A. Marchenko, I. Yu. Nikonorov, M. P. Grudinin
Publikováno v:
Infekciâ i Immunitet, Vol 0, Iss 0 (2019)
Currently, the assessment of the immunogenic properties of influenza viruses as a part of influenza vaccines is carried out by using seroprotection, seroconversion as well as the rate of increases in post-vaccination antibodies. At the same time, sig
Publikováno v:
Explosive Production of New Materials: Science, Technology, Business, and Innovations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb8bf91edd0eea743b082d65964d656
https://doi.org/10.30826/epnm18-099
https://doi.org/10.30826/epnm18-099
Autor:
E M, Voĭtsekhovskaia, V S, Vakin, A A, Vasil'eva, E V, Kuznetsova, V Z, Krivitskaia, A A, Sominina
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (12)
The article discusses the results of study that demonstrated the possibility of successful application of radial hemolysis reaction in analyzing the human inoculation immunity to new strains of influenza virus serotype A - A (H5N1) and A (H5N2). The
Autor:
V Z, Krivitskaia, N V, Tret'iakova, E V, Sorokin, T R, Tsareva, T D, Smirnova, E M, Voĭtsekhovskaia, V S, Vakin, E V, Kuznetsova, A A, Vasil'eva, N A, Medvedeva, V G, Maĭorova, A A, Sominina
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (10)
An indirect enzyme immunoassay (EIA) using the purified fraction of surface viral glycoproteins (GP) as an antigen for solid phase sensitization was not shown to be a specific method for the differential detection of influenza A(HS) (HS-Ab) virus ant
Publikováno v:
Voprosy virusologii. 27(4)
The pattern of redistribution of human virulence in epidemic strains of influenza viruses in recombination with human avirulent strains was studied. In the course of recombination of epidemic and attenuated influenza virus strains variants with diffe
Autor:
M P, Zykov, R P, Shaposhnikova, R I, Vasil'eva, T I, Subbotina, L G, Rudenko, M A, Gordon, V S, Vakin
Publikováno v:
Journal of hygiene, epidemiology, microbiology, and immunology. 27(4)
The effect of vaccine dilution and composition on indices of vaccination activity was studied in a live allantoic influenza vaccine administered intranasally to adults. The vaccine was shown to be usable in a 1:1 (instead of 1:5) dilution without ris
Publikováno v:
Acta virologica. 31(5)
Influenza virus recombinants between epidemic strains A/Brazil/11/78 (H1N1), A/USSR/382/78 (H3N2) and vaccine strains A/Leningrad/9/46 (H1N1), A/Victoria/35/72/50 (H3N2) have been tested for virulence for humans and albino mice; their genome structur